Clinical research study Aortic dissections and intramural hematoma| Volume 71, ISSUE 4, P1077-1087.e2, April 01, 2020

STABLE II clinical trial on endovascular treatment of acute, complicated type B aortic dissection with a composite device design

Published:August 30, 2019DOI:https://doi.org/10.1016/j.jvs.2019.06.189

      Abstract

      Objective

      To evaluate the safety and effectiveness of a composite device design (covered stent graft and bare metal stent) for the treatment of patients with acute, complicated type B aortic dissection (TBAD) presenting with aortic rupture and/or branch vessel malperfusion.

      Methods

      In this prospective, nonrandomized, multicenter study, 73 patients (65.8% male; mean age, 60.7 years) with acute, complicated TBAD were enrolled between August 2012 and January 2015 to receive treatment with the Zenith Dissection Endovascular System (William Cook Europe, Aps, Bjaeverskov, Denmark) at institutions in the United States and Japan. The primary safety end point was the rate of freedom from major adverse events at 30 days, and the primary effectiveness end point was the rate of survival at 30 days. This article reports primary outcomes at 30 days and follow-up results through 1 year, reflecting study data as of March 2018.

      Results

      Of 73 patients, 20 presented with aortic rupture (27%) and 57 presented with branch vessel obstruction/compromise (78%), including 4 patients presenting with both conditions. The covered stent graft was used in all patients (median, 1; range, 1-3; 1 stent graft used in 64.4%; 47/73), and the bare metal dissection stent was used in 58 of 73 patients (79.5%). Thirty-day mortality occurred in five patients (6.8%): one procedure related, three unrelated to dissection repair, and one indeterminate. Thirty-day major adverse events included myocardial infarction (1.4%), bowel ischemia (1.4%), renal insufficiency/renal failure requiring dialysis (6.8%), stroke (6.8%), paraplegia or paraparesis (5.5%), and prolonged ventilatory support (13.7%). Nine deaths occurred from 31 to 365 days (only one death related to dissection repair); the Kaplan-Meier estimate of freedom from all-cause mortality was 80.3% ± 4.7% at 1 year. Within 365 days, 9 of 73 patients (12.3%) underwent 10 secondary interventions; no patients required conversion to open surgery. At the 12-month follow-up, complete or partial thrombosis of the false lumen was seen in 100% of patients (46/46) within the stent graft region and in 97.4% of patients (38/39) within the dissection stent region. Growth (>5 mm) of the maximum transaortic diameter was observed in 14.9% of patients (7/47) in the stent graft region and in 38.5% of patients (15/39) within the dissection stent region at 12 months.

      Conclusions

      Thirty-day and 1-year results from the STABLE II study demonstrated favorable clinical and anatomical outcomes for the treatment of rupture and malperfusion in the setting of acute, complicated TBAD. Five-year follow-up is ongoing.

      Keywords

      To read this article in full you will need to make a payment
      SVS Member Login
      Society Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Umana J.P.
        • Miller D.C.
        • Mitchell R.S.
        What is the best treatment for patients with acute type B aortic dissections--medical, surgical, or endovascular stent-grafting?.
        Ann Thorac Surg. 2002; 74 (discussion: S1857-63): S1840-S1843
        • Trimarchi S.
        • Nienaber C.A.
        • Rampoldi V.
        • Myrmel T.
        • Suzuki T.
        • Bossone E.
        • et al.
        Role and results of surgery in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD).
        Circulation. 2006; 114: I357-I364
        • Dake M.D.
        Endovascular stent-graft management of thoracic aortic diseases.
        Eur J Radiol. 2001; 39: 42-49
        • Abel D.
        • Morales J.P.
        Food and Drug Administration commentary on the SVS masterfile for acute complicated type B aortic dissections and transections.
        J Vasc Surg. 2011; 53: 1079-1081
        • Fattori R.
        • Cao P.
        • De Rango P.
        • Czerny M.
        • Evangelista A.
        • Nienaber C.
        • et al.
        Interdisciplinary expert consensus document on management of type B aortic dissection.
        J Am Coll Cardiol. 2013; 61: 1661-1678
        • Mossop P.J.
        • McLachlan C.S.
        • Amukotuwa S.A.
        • Nixon I.K.
        Staged endovascular treatment for complicated type B aortic dissection.
        Nat Clin Pract Cardiovasc Med. 2005; 2 (quiz 322): 316-321
        • Nienaber C.A.
        • Kische S.
        • Zeller T.
        • Rehders T.C.
        • Schneider H.
        • Lorenzen B.
        • et al.
        Provisional extension to induce complete attachment after stent-graft placement in type B aortic dissection: the PETTICOAT concept.
        J Endovasc Ther. 2006; 13: 738-746
        • Melissano G.
        • Bertoglio L.
        • Kahlberg A.
        • Baccellieri D.
        • Marrocco-Trischitta M.M.
        • Calliari F.
        • et al.
        Evaluation of a new disease-specific endovascular device for type B aortic dissection.
        J Thorac Cardiovasc Surg. 2008; 136: 1012-1018
        • Lombardi J.V.
        • Cambria R.P.
        • Nienaber C.A.
        • Chiesa R.
        • Teebken O.
        • Lee A.
        • et al.
        Prospective multicenter clinical trial (STABLE) on the endovascular treatment of complicated type B aortic dissection using a composite device design.
        J Vasc Surg. 2012; 55: 629-640.e622
        • Lombardi J.V.
        • Cambria R.P.
        • Nienaber C.A.
        • Chiesa R.
        • Mossop P.
        • Haulon S.
        • et al.
        Aortic remodeling after endovascular treatment of complicated type B aortic dissection with the use of a composite device design.
        J Vasc Surg. 2014; 59: 1544-1554
        • White R.A.
        • Miller D.C.
        • Criado F.J.
        • Dake M.D.
        • Diethrich E.B.
        • Greenberg R.K.
        • et al.
        Report on the results of thoracic endovascular aortic repair for acute, complicated, type B aortic dissection at 30 days and 1 year from a multidisciplinary subcommittee of the Society for Vascular Surgery Outcomes Committee.
        J Vasc Surg. 2011; 53: 1082-1090
        • Hagan P.G.
        • Nienaber C.A.
        • Isselbacher E.M.
        • Bruckman D.
        • Karavite D.J.
        • Russman P.L.
        • et al.
        The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease.
        JAMA. 2000; 283: 897-903
        • Cambria R.P.
        • Conrad M.F.
        • Matsumoto A.H.
        • Fillinger M.
        • Pochettino A.
        • Carvalho S.
        • et al.
        Multicenter clinical trial of the conformable stent graft for the treatment of acute, complicated type B dissection.
        J Vasc Surg. 2015; 62: 271-278
        • Bavaria J.E.
        • Brinkman W.T.
        • Hughes G.C.
        • Khoynezhad A.
        • Szeto W.Y.
        • Azizzadeh A.
        • et al.
        Outcomes of Thoracic Endovascular Aortic Repair in Acute Type B Aortic Dissection: results From the Valiant United States Investigational Device Exemption Study.
        Ann Thorac Surg. 2015; 100 (discussion: 808-9): 802-808
        • Sobocinski J.
        • Lombardi J.V.
        • Dias N.V.
        • Berger L.
        • Zhou Q.
        • Jia F.
        • et al.
        Volume analysis of true and false lumens in acute complicated type B aortic dissections after thoracic endovascular aortic repair with stent grafts alone or with a composite device design.
        J Vasc Surg. 2016; 63: 1216-1224
        • Sobocinski J.
        • Dias N.
        • Hongku K.
        • Lombardi J.V.
        • Zhou Q.
        • Saunders A.
        • et al.
        SS31. TEVAR with stent grafts alone or with a composite device design in patients with acute type B aortic dissection in the setting of malperfusion.
        J Vasc Surg. 2018; 67: e239-e240
        • Famularo M.
        • Meyermann K.
        • Lombardi J.V.
        Aneurysmal degeneration of type B aortic dissections after thoracic endovascular aortic repair: a systematic review.
        J Vasc Surg. 2017; 66: 924-930